Role of pancreatic stellate cells and periostin in pancreatic cancer progression

Tumor Biology

Volumn 36, Issue 5, 2015, Pages 3171-3177

  Liu, Yang ^a   Du, Lianfang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Extracellular matrix; Pancreatic ductal adenocarcinoma; Pancreatic stellate cells; Periostin; Stroma

Indexed keywords

ISOPROTEIN; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ANGIOGENESIS; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; DISEASE COURSE; HUMAN; HYPOXIA; MICROENVIRONMENT; NONHUMAN; PANCREAS CANCER; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STARVATION; STROMA; TUMOR MICROENVIRONMENT; ANIMAL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL ADHESION MOLECULES; DISEASE PROGRESSION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; SIGNAL TRANSDUCTION;

EID: 84929952507     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3386-2     Document Type: Review

References (46)

1. Viale A. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014;514:628–32.
2. Xu Z. Pancreatic cancer and its stroma: a conspiracy theory. World J Gastroenterol. 2014;20:11216–29.
3. Erkan M. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9:454–67.
4. Bachem MG. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907–21.
5. Erkan M. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2008;6:1155–61.
6. Wilson JS. Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression. Front Physiol. 2014;5:52.
7. Duner S. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology. 2010;10:673–81.
8. Haqq J. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Eur J Cancer. 2014;50:2570–82.
9. Haage A, Schneider IC. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells. FASEB J. 2014;28:3589–99.
10. Takeshita S. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294(Pt 1):271–8.
11. Ruan K. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 2009;66:2219–30.
12. Ben QW. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer. Oncol Rep. 2011;25:709–16.
13. Erkan M. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology. 2007;132:1447–64.
14. Xu D. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One. 2012;7:e46670.
15. Morra L. Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer. 2012;76:183–90.
16. Sasaki H. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg. 2002;37:1293–7.
17. Baril P. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene. 2007;26:2082–94.
18. Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int. 2012;23:1199–212.
19. Conway SJ. The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. Sci World J. 2011;11:1509–24.
20. Romanos GE. PERIOSTIN: role in formation and maintenance of dental tissues. J Cell Physiol. 2014;229:1–5.
21. Rios H. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 2005;25:11131–44.
22. Tkatchenko TV. Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol Genomics. 2009;39:160–8.
23. Lie-Venema H. Periostin expression by epicardium-derived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton. Differentiation. 2008;76:809–19.
24. Zhao S. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol. 2014;63:373–8.
25. Stansfield WE. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg. 2009;88:1916–21.
26. Li J. [Roles of periostin in proliferation and migration of vascular smooth muscle cells and the effect of atorvastatin on them]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37:689–94.
27. Rani S. Induction of periostin-like factor and periostin in forearm muscle, tendon, and nerve in an animal model of work-related musculoskeletal disorder. J Histochem Cytochem. 2009;57:1061–73.
28. Goetsch SC. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics. 2003;14:261–71.
29. Rousseau JC. Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. J Clin Endocrinol Metab. 2014;99:2533–9.
30. Nuzzo PV. Periostin: a novel prognostic and therapeutic target for genitourinary cancer? Clin Genitourin Cancer. 2014;12:301–11.
31. Gillan L. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha (V) beta (3) and alpha (V) beta (5) integrins and promotes cell motility. Cancer Res. 2002;62:5358–64.
32. Kim CJ. Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol. 2008;32:161–9.
33. Apte MV. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43:128–33.
34. Apte MV. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004;29:179–87.
35. Heinemann V. Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. Cancer Treat Rev. 2014;40:118–28.
36. Yoshitomi H. Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer. Pancreas. 2008;37:275–81.
37. Froeling FE. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells. Am J Pathol. 2009;175:636–48.
38. Vonlaufen A. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68:2085–93.
39. Hwang RF. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918–26.
40. Erkan M. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia. 2009;11:497–508.
41. Gemcitabine plus bevacizumab no better than gemcitabine alone in clinical study of 600 patients with pancreatic cancer. Cancer Biol Ther. 2007;6:137.
42. Reiser-Erkan C. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2008;7:1352–9.
43. Couvelard A. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology. 2005;46:668–76.
44. Erkan M. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61:172–8.
45. Kanno A. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer. 2008;122:2707–18.
46. Conway SJ. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014;71:1279–88.